ECONOMIC IMPACT OF NON-RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS

被引：0
|
作者：
Sharma, Parivrudh [1 ]
Crighton, Lynne [2 ]
Vijayan, Balasubramaniam [3 ]
English, Shirley [3 ]
Mukhopadhya, Ashis [3 ]
机构：
[1] Univ Aberdeen, Aberdeen, Scotland
[2] Aberdeen Royal Infirm, Pharm Dept, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Digest Disorders, Aberdeen, Scotland
来源：
GUT | 2019年 / 68卷
关键词：
D O I：
10.1136/gutjnl-2019-BSGAbstracts.244
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-035
引用
收藏
页码：A129 / A130
页数：2
相关论文
共 50 条
  • [21] A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
    Li, Chunlei
    Zheng, Kunyu
    Chen, Yiran
    He, Chengmei
    Liu, Suying
    Yang, Yunjiao
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Li
    Zhang, Fengchun
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [22] Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
    van Hooff, M. C.
    Werner, E.
    van der Meer, A. J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 14 - 21
  • [23] Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
    Namisaki, T.
    Fujinaga, Y.
    Moriya, K.
    Kitade, M.
    Kaji, K.
    Kawaratani, H.
    Seki, K.
    Takaya, H.
    Sato, S.
    Sawada, Y.
    Akahane, T.
    Yoshiji, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S224 - S224
  • [24] Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
    Fujinaga, Yukihisa
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Kawaratani, Hideto
    Kaji, Kosuke
    Okura, Yasushi
    Seki, Kenichiro
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Akahane, Takemi
    Nishimura, Norihisa
    Sato, Shinya
    Shimozato, Naotaka
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Kubo, Takuya
    Furukawa, Masanori
    Yoshiji, Hitoshi
    HEPATOLOGY, 2017, 66 : 196A - 196A
  • [25] The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis
    Namisaki, Tadashi
    Fujinaga, Yukihisa
    Moriya, Kei
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2021, 51 (01) : 31 - 38
  • [26] The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
    Kawata, Kazuhito
    Joshita, Satoru
    Shimoda, Shinji
    Yamashita, Yuki
    Yamashita, Maho
    Kitsugi, Kensuke
    Takatori, Shingo
    Ohta, Kazuyoshi
    Ito, Jun
    Shimoyama, Shin
    Noritake, Hidenao
    Suda, Takafumi
    Harada, Kenichi
    HEPATOLOGY RESEARCH, 2021, 51 (01) : 80 - 89
  • [27] Bezafibrate for primary biliary Cholangitis "Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial"
    Klose, G.
    Nitschmann, S.
    INTERNIST, 2018, 59 (12): : 1344 - 1346
  • [28] Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
    Liu, Benjamin D.
    Qureshi, Kamran
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 346 - 348
  • [29] Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
    Benjamin D. Liu
    Kamran Qureshi
    Digestive Diseases and Sciences, 2023, 68 : 346 - 348
  • [30] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
    Tanaka, Atsushi
    Hirohara, Junko
    Nakano, Toshiaki
    Yagi, Minami
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    Nakanuma, Yasuni
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
12345